Soleno Therapeutics Statistics
Total Valuation
SLNO has a market cap or net worth of $4.31 billion. The enterprise value is $4.07 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SLNO has 53.15 million shares outstanding. The number of shares has increased by 50.95% in one year.
Current Share Class | 53.15M |
Shares Outstanding | 53.15M |
Shares Change (YoY) | +50.95% |
Shares Change (QoQ) | +9.32% |
Owned by Insiders (%) | 1.39% |
Owned by Institutions (%) | 105.16% |
Float | 43.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 91.21 |
PS Ratio | 113.39 |
Forward PS | 36.41 |
PB Ratio | 17.04 |
P/TBV Ratio | 18.40 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 124.66 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.13, with a Debt / Equity ratio of 0.22.
Current Ratio | 15.13 |
Quick Ratio | 14.87 |
Debt / Equity | 0.22 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -62.78 |
Financial Efficiency
Return on equity (ROE) is -69.53% and return on invested capital (ROIC) is -40.58%.
Return on Equity (ROE) | -69.53% |
Return on Assets (ROA) | -36.60% |
Return on Invested Capital (ROIC) | -40.58% |
Return on Capital Employed (ROCE) | -59.84% |
Revenue Per Employee | $354,967 |
Profits Per Employee | -$1.97M |
Employee Count | 92 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.23% in the last 52 weeks. The beta is -2.56, so SLNO's price volatility has been lower than the market average.
Beta (5Y) | -2.56 |
52-Week Price Change | +73.23% |
50-Day Moving Average | 82.83 |
200-Day Moving Average | 63.08 |
Relative Strength Index (RSI) | 45.02 |
Average Volume (20 Days) | 1,179,326 |
Short Selling Information
The latest short interest is 6.04 million, so 11.37% of the outstanding shares have been sold short.
Short Interest | 6.04M |
Short Previous Month | 5.87M |
Short % of Shares Out | 11.37% |
Short % of Float | 13.87% |
Short Ratio (days to cover) | 4.40 |
Income Statement
In the last 12 months, SLNO had revenue of $32.66 million and -$181.08 million in losses. Loss per share was -$3.97.
Revenue | 32.66M |
Gross Profit | 31.96M |
Operating Income | -186.32M |
Pretax Income | -65.41M |
Net Income | -181.08M |
EBITDA | -184.32M |
EBIT | -186.32M |
Loss Per Share | -$3.97 |
Full Income Statement Balance Sheet
The company has $286.84 million in cash and $52.77 million in debt, giving a net cash position of $241.07 million or $4.54 per share.
Cash & Cash Equivalents | 286.84M |
Total Debt | 52.77M |
Net Cash | 241.07M |
Net Cash Per Share | $4.54 |
Equity (Book Value) | 240.14M |
Book Value Per Share | 4.76 |
Working Capital | 295.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$84.28 million and capital expenditures -$213,000, giving a free cash flow of -$84.49 million.
Operating Cash Flow | -84.28M |
Capital Expenditures | -213,000 |
Free Cash Flow | -84.49M |
FCF Per Share | -$1.59 |
Full Cash Flow Statement Margins
Gross Margin | 97.87% |
Operating Margin | -570.55% |
Pretax Margin | -554.49% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SLNO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -50.95% |
Shareholder Yield | -50.95% |
Earnings Yield | -4.20% |
FCF Yield | -1.96% |
Analyst Forecast
The average price target for SLNO is $110.22, which is 35.84% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $110.22 |
Price Target Difference | 35.84% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Aug 26, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
SLNO has an Altman Z-Score of 13.13 and a Piotroski F-Score of 1.
Altman Z-Score | 13.13 |
Piotroski F-Score | 1 |